Patent directory · USPTO A61K / A61P
Patents matching “mesenchymal”
37 pharma patents match "mesenchymal" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 37 pharmaceutical patents matching "mesenchymal" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12274684
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
granted -
US 12263165
Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
granted -
US 12226437
Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell expressing IGF1R and method for obtaining multipotent umbilical cord mesenchymal stem cell
granted -
US 12209255
Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
granted -
US 12171786
Use of mesenchymal stem cells for the treatment of inflammation
granted -
US 12116596
Method and apparatus for improved mesenchymal stem cell harvesting
granted -
US 12097223
Mesenchymal stromal cells and uses related thereto
granted -
US 12064453
Biochemical and biomechanical conditioning for enhancing personalized mesenchymal stem cell therapies
granted -
US 11857575
Mesenchymal stem cell-derived exosomes and their uses
granted -
US 11839596
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
granted -
US 11802272
Enrich and amplify highly potent human mesenchymal stem cells from elderly cell populations
granted -
US 11759461
Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
granted -
US 11666602
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
granted -
US 11655454
Method and apparatus for improved mesenchymal stem cell harvesting
granted -
US 11529373
Method for enhancing expression of insulin like growth factor 1 receptor in mesenchymal stem cell, method for obtaining mesenchymal stem cell, and method for treating brain tissue damage
granted -
US 11185572
Mesenchymal stem cells for the treatment of CNS diseases
granted -
US 11186873
Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)
granted -
US 11141393
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
granted -
US 11098053
Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells
granted -
US 10842826
Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
granted -
US 10660918
Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem cell, method for isolating mesenchymal stem cell, and use of mesenchymal stem cell
granted -
US 10564149
Populations of mesenchymal stem cells that secrete neurotrophic factors
granted -
US 10329353
Specific detection tool for mesenchymal and epithelial-mesenchymal transformed circulating tumor cells
granted -
US 10292986
Methods for treating epithelian mesenchymal transition related diseases
granted